Package 31722-557-60

{"route": ["ORAL"], "spl_id": "2b451c79-7df8-d0f9-e063-6294a90a5fcf", "openfda": {"upc": ["0331722557603"], "unii": ["J220T4J9Q2"], "rxcui": ["242679"], "spl_set_id": ["44fb1e25-ad03-4a7f-9f35-2e29f5025661"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (31722-557-60)", "package_ndc": "31722-557-60", "marketing_start_date": "20210401"}], "brand_name": "Abacavir", "product_id": "31722-557_2b451c79-7df8-d0f9-e063-6294a90a5fcf", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-557", "generic_name": "Abacavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA091560", "marketing_category": "ANDA", "marketing_start_date": "20210401", "listing_expiration_date": "20261231"}